The in vitro activity of nafcillin, oxacillin, and methicillin alone and in combination with gentamicin and tobramycin against 30 strains of enterococci was investigated. The penicillinase-resistant penicillins were less active than penicillin and ampicillin against the enterococci. Nafcillin was more active than oxacillin and methicillin. Sixty-six percent of strains were inhibited by nafcillin at 6.25 ,ug/ml, but none was inhibited by oxacillin and methicillin at the same concentration. At 12.5 ,ug/ml, 83, 16, and 0% were inhibited by nafcillin, oxacillin, and methicillin, respectively. By using a variety of criteria and analyses, it was shown that none of the antibiotic combinations studied demonstrated enhanced killing ofall strains of enterococci. Nafcillin-gentamicin was the best combination, and enhanced killing was demonstrated against most strains. Oxacillin was more effective than methicillin when combined with gentamicin. Tobramycin was probably less effective than gentamicin in combination with the penicillinase-resistant penicillins against enterococci.
The combination of a penicillinase-resistant penicillin and gentamicin is often used in the empirical antimicrobial therapy of suspected sepsis because of its spectrum against Staphylococcus aureus, Pseudomonas aeruginosa, and other gram-negative bacilli. However, neither the penicillinase-resistant penicillins nor the aminoglycosides alone were very effective against enterococci. The adequacy of such a combination in clinical situations where enterococcal infection is a possibility is not certain. It is especially important in a heroin addict who may have endocarditis caused by S. aureus, P. aeruginosa, or an enterococcus (1, 10) . Although good universal synergism of the combination of penicillin and gentamicin against enterococci has been demonstrated (8, 9, 11, 15, 17) , there have been only limited data regarding the synergistic activity of nafcillin, oxacillin, or methicillin in combination with gentamicin against enterococci. Furthermore, conflicting results were obtained (3, 7) . Tobramycin, a recently released aminoglycoside with an in vitro antimicrobial spectrum and clinical pharmacology similar to that of gentamicin, is now used instead of gentamicin by some clinicians. There have been no data regarding the effects of the combination of tobramycin with nafcillin, oxacillin, or methicillin against enterococci.
This study was undertaken to determine the bactericidal effects of the three penicillinaseresistant penicillins against enterococci alone and in combination with gentamicin or tobramycin.
MATERIALS AND METHODS Enterococci. Thirty strains of enterococci were studied, 21 of which were isolated from blood cultures of patients with endocarditis. All strains were gram-positive cocci in chains, grew as nonhemolytic or alpha-hemolytic colonies on sheep blood agar, gave a positive reaction on bile-esculin agar, and grew in 6.5% NaCl brain heart infusion broth.
Antibiotic susceptibility test. The minimal inhibitory concentrations (MICs) of penicillin G, ampicillin, nafcillin, oxacillin, methicillin, gentamicin, and tobramycin were determined by the ICS agar dilution method (2) . Mueller-Hinton agar was used. The inoculum was 0.002 ml of a 10-2 dilution of an overnight culture (approximately 103 to 104 organisms) delivered by a Steers replicator (13) .
Test for synergism. The time-kill curve method was utilized. The enterococci were grown overnight and diluted with Mueller-Hinton broth to give between 106 and 107 colony-forming units (CFU) per ml and incubated with different antibiotics in a water bath at 37°C. The final concentrations of antibiotics were as follows: (i) nafcillin, 20 pAg/ml; oxacillin, 20 ,ug/ml; methicillin, 20 ,ug/ml; (ii) gentamicin, 4 
RESULTS
The MICs of the five penicillins and two aminoglycosides for the 30 strains of enterococci are listed in Table 1 . The penicillinase-resistant penicillins were much less active than penicillin and ampicillin against enterococci. Nafcillin was more active than oxacillin and methicillin. As expected, all enterococci were resistant to gentamicin and tobramycin. Tobramycin was much less active than gentamicin. Figure 1 shows the effects of nafcillin, oxacillin, methicillin, gentamicin, and tobramycin alone in killing enterococci. Among the penicillinase-resistant penicillins tested, nafcillin was the best in comparison with oxacillin and methicillin. In general, gentamicin and tobramycin had negligible effects in killing enterococci; some killing did occur with a few strains.
The effects of the antibiotic combinations in comparison with single antibiotics against the 30 strains of enterococci are shown in Table 2 . The data were analyzed according to the magnitude of increase in the killing of enterococci (2 10-fold, 2100-fold, and .1,000-fold) as compared with the most effective antibiotic alone at different time intervals (6, 24 , and 48 h). In general, the enhancement of killing became more obvious as the period of incubation increased. No antibiotic combination tested demonstrated enhanced killing of all strains of enterococci tested. There were more strains showing enhanced killing by the combination of oxacillin and gentamicin than by the nafcillin-gen- tamicin and methicillin-gentamicin combinations. However, in the case of the nafcillingentamicin combination, the apparent less enhancement of killing by the combination was due partly to the much greater effectiveness of nafcillin than oxacillin alone in killing enterococci (Fig. 1) , resulting in less difference in viable CFU when gentamicin was added. It is worth noting that at 48 h a-1,000-fold decrease in viable CFU was demonstrated in the largest number of strains when nafcillin-gentamicin and nafcillin-tobramycin were tested.
For all strains tested, none of the culture systems became sterile at the end of 6, 24, or 48 h. Data were then analyzed according to the number of viable CFU at 6, 24, and 48 h. Table  3 shows the number of strains with <9 x 103 viable CFU per ml in different antibiotic combinations. If a stricter criterion is used, namely the number of strains with <9 x 102 viable CFU per ml, the results are as follows: at 6 h, none; at 24 h, one strain with the nafcillin-gentamicin combination and two strains with the nafcillin-tobramycin combination; at 48 h, eight and ten strains with the nafcillin-gentamicin and nafcillin-tobramycin combinations, respectively, and one strain each with the oxacillin-gentamicin and oxacillin-tobramycin combinations. Thus, nafcillin-gentamicin and nafcillin-tobramycin were the most effective combinations in reducing viable CFU. Nafcillin was more effective than oxacillin and methicillin in killing enterococci when it was used alone. In combination with gentamicin or tobramycin, nafcillin was also superior to oxacillin and methicillin. Gentamicin was probably more effective than tobramycin when used in combination with methicillin, oxacillin, or methicillin against enterococci. DISCUSSION There have been few data regarding the in vitro susceptibility of enterococci to the penicil- (3, 14) . In our study, 100%o of enterococcal strains tested were inhibited by penicillin and ampicillin at 6.25 mg/ml, whereas only 66%
were inhibited by nafcillin and 0% by oxacillin and methicillin at the same concentration. At 12.5 ,ug/ml, 83, 16, and 0% were inhibited, and at 25 ,ug/ml, 86, 73, and 23% were inhibited by nafcillin, oxacillin, and methicillin respectively. Our data were comparable with those of two other studies and showed that nafcillin was the most active of the three penicillinase-resistant penicillins against enterococci (3, 4) . It has been shown that penicillin, ampicillin, amoxicillin, carbenicillin, or vancomycin in combination with gentamicin gives enhanced killing of enterococci (4-6, 8, 9, 11, 12, 15-17) . However, no uniform results were obtained regarding combinations of a penicillinase-resistant penicillin and gentamicin against enterococci. Glew et al. studied 14 strains of enterococci by the time-kill curve method and reported synergism of the nafcillin-gentamicin combination against 10 of 14 strains, whereas oxacillin-gentamicin and methicillin-gentamicin were synergistic against only three and one strains, respectively (3) . By using a different method (checkerboard), Marier et al. reported synergism by the oxacillin-gentamicin combination against 27 of 34 strains of enterococci studied (7) . In our studies, by using a variety of criteria and types of analyses similar to those used by Glew et al., it was shown that none of the combinations studied demonstrated enhanced killing of all strains of enterococci. Nafcillin-gentamicin was the best combination; significant enhanced killing was demonstrated against most strains. Oxacillin was more effective than methicillin when combined with gentamicin.
Tobramycin has not been studied extensively against enterococci. One study reported that tobramycin was less active than gentamicin against enterococci, the MIC being >250 ,ug/ml for about 15% of the strains (9) . In this same study it was shown that whereas the penicillingentamicin combination was synergistic against all 27 strains of enterococci tested, the penicillin-tobramycin combination was ineffective against 4 strains; all 4 strains were Streptococcus faecium. In our study, the MIC of tobramycin for 8 of 30 strains (26%) was >200 ,ug/ ml. It was also shown that tobramycin was probably less effective than gentamicin in combination with the penicillinase-resistant penicillins against enterococci. 
